These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33482616)

  • 1. CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development.
    Mlost J; Kostrzewa M; Borczyk M; Bryk M; Chwastek J; Korostyński M; Starowicz K
    Biomed Pharmacother; 2021 Apr; 136():111283. PubMed ID: 33482616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development.
    Mlost J; Kac P; Kędziora M; Starowicz K
    Neuropharmacology; 2022 Feb; 204():108908. PubMed ID: 34856202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury.
    Li L; Luo Q; Shang B; Yang X; Zhang Y; Pan Q; Wu N; Tang W; Du D; Sun X; Jiang L
    Exp Neurol; 2022 Jan; 347():113899. PubMed ID: 34678230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cannabinoid CB
    Salort G; Álvaro-Bartolomé M; García-Sevilla JA
    Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
    Alsalem M; Haddad M; Aldossary SA; Kalbouneh H; Altarifi A; Jaffal SM; Abbas MA; Aldaoud N; El-Salem K
    Inflammopharmacology; 2019 Dec; 27(6):1131-1142. PubMed ID: 30945071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
    O'Brien M; McDougall JJ
    Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.
    McDougall JJ; Yu V; Thomson J
    Br J Pharmacol; 2008 Jan; 153(2):358-66. PubMed ID: 17982474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice.
    Jafari MR; Golmohammadi S; Ghiasvand F; Zarrindast MR; Djahanguiri B
    Behav Pharmacol; 2007 Nov; 18(7):691-7. PubMed ID: 17912054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint.
    Burston JJ; Sagar DR; Shao P; Bai M; King E; Brailsford L; Turner JM; Hathway GJ; Bennett AJ; Walsh DA; Kendall DA; Lichtman A; Chapman V
    PLoS One; 2013; 8(11):e80440. PubMed ID: 24282543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases.
    Hashiesh HM; Jha NK; Sharma C; Gupta PK; Jha SK; Patil CR; Goyal SN; Ojha SK
    Eur J Pharmacol; 2021 Oct; 909():174398. PubMed ID: 34332924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor type 2 is upregulated in synovium following joint injury and mediates anti-inflammatory effects in synovial fibroblasts and macrophages.
    Rzeczycki P; Rasner C; Lammlin L; Junginger L; Goldman S; Bergman R; Redding S; Knights AJ; Elliott M; Maerz T
    Osteoarthritis Cartilage; 2021 Dec; 29(12):1720-1731. PubMed ID: 34537380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
    Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N
    J Physiol Sci; 2015 Sep; 65(5):407-15. PubMed ID: 25894754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
    Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
    Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cannabinoid system and pain: towards new drugs?].
    Beltramo M
    J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
    de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
    Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.